Results 221 to 230 of about 11,731,529 (403)

Enterprise modelling for decision-making in the software ecosystem. [PDF]

Sci Rep
Rani A, Mishra D, Omerovic A.
europepmc   +1 more source

An Analysis of Power and Its Role in the Decision-Making Process of the Formal Organization.

, 1964
Ogden Hall
openalex   +2 more sources

Integration of single‐cell and bulk RNA‐sequencing data reveals the prognostic potential of epithelial gene markers for prostate cancer

Molecular Oncology, EarlyView.
Prostate cancer is a leading malignancy with significant clinical heterogeneity in men. An 11‐gene signature derived from dysregulated epithelial cell markers effectively predicted biochemical recurrence‐free survival in patients who underwent radical surgery or radiotherapy.
Zhuofan Mou, Lorna W. Harries
wiley   +1 more source

Choice history biases in dyadic decision making. [PDF]

Sci Rep
Huang A, Pink M, Zemliak V, Czeszumski A, König P.   +4 more
europepmc   +1 more source

Analyzing the Use of Information in Investment Decision Making: A Methodological Proposal [PDF]

, 1972
Paul Slovic, Dan Fleissner, W. Scott Bauman   +2 more
openalex   +1 more source

Decision-Making Under Moral Uncertainty [PDF]

, 2018
Sepielli, Andrew
core   +1 more source

Clinical significance of stratifying prostate cancer patients through specific circulating genes

Molecular Oncology, EarlyView.
We tested a specific panel of genes representative of luminal, neuroendocrine and stem‐like cells in the blood of prostate cancer patients, showing predictive value from diagnosis to late stages of disease. This approach allows monitoring of treatment responses and outcomes at specific time points in trajectories.
Seta Derderian, Edouard Jarry, Arynne Santos, Quentin Vesval, Lucie Hamel, Rafael Sanchez‐Salas, Alexis Rompré‐Brodeur, Wassim Kassouf, Raghu Rajan, Fadi Brimo, Marie Duclos, Armen Aprikian, Simone Chevalier   +12 more
wiley   +1 more source

The value of initiating a pursuit in temporal decision-making. [PDF]

Elife
Sutlief E, Walters C, Marton T, Hussain Shuler MG.   +3 more
europepmc   +1 more source

Post-investment analysis and decision making

, 1969
James Clyde Sprague
openalex   +1 more source

MET variants with activating N‐lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation

Molecular Oncology, EarlyView.
MET variants in the N‐lobe of the kinase domain, found in hereditary papillary renal cell carcinoma, require ligand stimulation to promote cell transformation, in contrast to other RTK variants. This suggests that HGF expression in the microenvironment is important for tumor growth in such patients. Their sensitivity to MET inhibitors opens the way for
Célia Guérin, Audrey Vinchent, Marie Fernandes, Isabelle Damour, Agathe Laratte, Rémi Tellier, Gabriella O. Estevam, Jean‐Pascal Meneboo, Céline Villenet, Clotilde Descarpentries, James S. Fraser, Martin Figeac, Alexis B. Cortot, Etienne Rouleau, David Tulasne   +14 more
wiley   +1 more source